[Retracted] The Molecular Mechanism of Hepatic Lipid Metabolism Disorder Caused by NaAsO2 through Regulating the ERK/PPAR Signaling Pathway
Liping Wu, Shuling Zhang, Qi Zhang, Shaofeng Wei, Guoze Wang, Peng Luo
Abstract
Chronic arsenic exposure is a risk factor for human fatty liver disease, and the ERK signaling pathway plays an important role in the regulation of liver lipid metabolism. However, whether ERK plays a role in the progression of arsenic‐induced liver lipid metabolism disorder and the specific mechanism remain unclear. Here, by constructing a rat model of liver lipid metabolism disorder induced by chronic arsenic exposure, we demonstrated that ERK might regulate arsenic‐induced liver lipid metabolism disorders through the PPAR signaling pathway. Arsenic could upregulate the expression of PPAR γ and CD36 in the rat liver, decrease the expression of PPAR α and CPT‐1 in the rat liver, increase the organ coefficient of the rat liver, decrease the content of TG in rat serum, and promote fat deposition in the rat liver. In the arsenic‐induced rat model of hepatic lipid metabolism disorder, we found that the expression of p ‐ERK was increased. In order to further explore whether the ERK signaling pathway was involved in arsenic‐induced liver lipid metabolism disorder, we exposed L‐02 cells to different arsenic concentrations, and the results showed that arsenic significantly increased the expression of P‐ERK in L‐02 cells in a dose‐dependent manner. We further treated L‐02 cells with ERK inhibitors and found that the expression of TG, PPAR α , and CPT‐1 in L‐02 cells increased, while the expression of P‐ERK, PPAR γ , and CD36 decreased. In conclusion, ERK may be involved in arsenic‐induced liver lipid metabolism disorder by regulating the PPAR signaling pathway. These findings are expected to provide a new targeting strategy for arsenic‐induced liver lipid metabolism disorder.